Home » Guidance Clarifies When PMA Supplement Needed
Guidance Clarifies When PMA Supplement Needed
January 13, 2009
The U.S. Food and Drug Administration (FDA) is recommending that devicemakers carefully assess which submission they need to file when they change manufacturing procedures for a product — either filing a 30-day notice or a special premarket approval (PMA) supplement.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor